BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24465548)

  • 21. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRI assessment of excess cardiac iron in thalassemia major: When to initiate?
    Chen X; Zhang Z; Zhong J; Yang Q; Yu T; Cheng Z; Chan Q; Guo H; Liang B
    J Magn Reson Imaging; 2015 Sep; 42(3):737-45. PubMed ID: 26154874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of global strain values of myocardium in beta-thalassemia major patients with iron load using specific feature tracking in cardiac magnetic resonance imaging.
    Rezaeian N; Mohtasham MA; Khaleel AJ; Parnianfard N; Kasani K; Golshan R
    Int J Cardiovasc Imaging; 2020 Jul; 36(7):1343-1349. PubMed ID: 32346846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major population.
    Di Odoardo LAF; Giuditta M; Cassinerio E; Roghi A; Pedrotti P; Vicenzi M; Sciumbata VM; Cappellini MD; Pierini A
    Intern Emerg Med; 2017 Sep; 12(6):799-809. PubMed ID: 28456904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spatial repolarization heterogeneity detected by magnetocardiography correlates with cardiac iron overload and adverse cardiac events in beta-thalassemia major.
    Chen CA; Lu MY; Peng SF; Lin KH; Chang HH; Yang YL; Jou ST; Lin DT; Liu YB; Horng HE; Yang HC; Wang JK; Wu MH; Wu CC
    PLoS One; 2014; 9(1):e86524. PubMed ID: 24475137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different patterns of myocardial iron distribution by whole-heart T2* magnetic resonance as risk markers for heart complications in thalassemia major.
    Meloni A; Restaino G; Borsellino Z; Caruso V; Spasiano A; Zuccarelli A; Valeri G; Toia P; Salvatori C; Positano V; Midiri M; Pepe A
    Int J Cardiol; 2014 Dec; 177(3):1012-9. PubMed ID: 25449516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular global function index is associated with myocardial iron overload and heart failure in thalassemia major patients.
    Meloni A; Positano V; Pistoia L; Righi R; Missere M; Grassedonio E; Schicchi N; Vallone A; Gamberini MR; Cuccia L; Lisi R; Cecinati V; Spasiano A; Cademartiri F
    Int J Cardiovasc Imaging; 2023 May; 39(5):991-999. PubMed ID: 36637709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T2* MRI in regularly transfused children with thalassemia intermedia: serum ferritin does not reflect liver iron stores.
    Tony S; Daar S; Elshinawy M; Al-Zadjaly S; Al-Khabori M; Wali Y
    Pediatr Hematol Oncol; 2012 Sep; 29(6):579-84. PubMed ID: 22839111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between myocardial T2 values and cardiac volumetric and functional parameters in β-thalassemia patients evaluated by cardiac magnetic resonance in association with serum ferritin levels.
    Liguori C; Pitocco F; Di Giampietro I; de Vivo AE; Schena E; Cianciulli P; Zobel BB
    Eur J Radiol; 2013 Sep; 82(9):e441-7. PubMed ID: 23639773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients.
    Cassinerio E; Roghi A; Orofino N; Pedrotti P; Zanaboni L; Poggiali E; Giuditta M; Consonni D; Cappellini MD
    Ann Hematol; 2015 Jun; 94(6):939-45. PubMed ID: 25563596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
    Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burden of Cardiac Siderosis in a Thalassemia-Major Endemic Population: A Preliminary Report From Pakistan.
    Alvi N; Tipoo FA; Imran A; Ashraf MN; Qidwai A; Khursheed M; Moiz B; Adil SN; Fadoo Z; Altaf S; Pennell DJ; Hasan BS
    J Pediatr Hematol Oncol; 2016 Jul; 38(5):378-83. PubMed ID: 27164519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major.
    Westwood MA; Wonke B; Maceira AM; Prescott E; Walker JM; Porter JB; Pennell DJ
    J Magn Reson Imaging; 2005 Aug; 22(2):229-33. PubMed ID: 16028255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac T2* MRI assessment in patients with thalassaemia major and its effect on the preference of chelation therapy.
    Akcay A; Salcioglu Z; Oztarhan K; Tugcu D; Aydogan G; Ayaz NA; Bornaun H; Sen HS; Akici F; Akdana B
    Int J Hematol; 2014 Jun; 99(6):706-13. PubMed ID: 24719246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of myocardial iron overload by two-dimensional speckle tracking in patients with beta-thalassaemia major: a combined echocardiographic and T2* segmental CMR study.
    Pizzino F; Meloni A; Terrizzi A; Casini T; Spasiano A; Cosmi C; Allò M; Zito C; Carerj S; Aquaro GD; Di Bella G; Pepe A
    Int J Cardiovasc Imaging; 2018 Feb; 34(2):263-271. PubMed ID: 28770456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac Iron Overload by MRI in Children With B-Thalassemia Major and its Correlation With Cardiac Function by Echocardiography.
    El-Shanshory M; Tolba O; El-Shafiey R; Elgamasy M; Hablas N; Mawlana W
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):398-402. PubMed ID: 32251156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major.
    Pathare A; Taher A; Daar S
    Ann Hematol; 2010 Apr; 89(4):405-9. PubMed ID: 19798501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between T2* cardiovascular magnetic resonance with left ventricular function and mass in adolescent and adult major thalassemia patients with iron overload.
    Djer MM; Anggriawan SL; Gatot D; Amalia P; Sastroasmoro S; Widjaja P
    Acta Med Indones; 2013 Oct; 45(4):295-301. PubMed ID: 24448334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A practical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac T2*.
    Ha SY; Mok AS; Chu WC; Raskalkar DD; Cheuk DK; Chiang AK; Ho MH; Chan GC
    Hemoglobin; 2009; 33(5):323-31. PubMed ID: 19814678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.